Nova Seminars Logo

Nova Biomedical presents an educational seminar on:
The Clinical Impact of Glucose Meter Accuracy in Critically Ill Patients – Including FDA news on capillary testing

A clinician’s treatment of critically ill patients can be undermined by inaccurate point-of-care (POC) glucose meter results. Inaccurate results are most often caused by interferences related to patient physiology and exogenous substances such as medications, therapeutics, and non-glucose sugars. Inaccurate glucose results put patients at risk for improper insulin dosing and missed hypoglycemic events, and have caused adverse events and even death. Using peer-reviewed evaluations and case studies, our seminar examines the risks associated with glucose meter testing in the presence of interferences.

This seminar will also address sample selection for all hospitalized patients, including an update on the FDA’s recent meeting and interest in capillary testing for critically ill patients.

Who should attend?
Nurses, POC coordinators, laboratory professionals, risk managers

 Featured Speakers

Martha E. Lyon, PhD
Clinical Biochemist/Clinical Associate Professor, Royal University Hospital Saskatoon
Saskatchewan, Canada
Nam K. Tran, PhD, MS
Associate Clinical Professor & Director of Clinical Chemistry and Point-of-Care Testing
University of California, Davis
Jeffery DuBois
Evan Ntrivalas, MD, PhD
Director of Medical &
Scientific Affairs
Nova Biomedical

This seminar provides 3.5 contact hours for P.A.C.E. and CERP continuing education credits. P.A.C.E. is a registered trademark of the American Society for Clinical Laboratory Science. Nova Biomedical is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. program. This program has been approved by the American Association of Critical-Care Nurses (AACN) for 3.5 Synergy CERPs Category A, File Number 22159.

Register here.